New gel could ease menstrual cramps without pills
NCT ID NCT05752526
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-stage trial tested a vaginal gel containing diclofenac, a common pain reliever, in 42 women with painful periods. The gel is designed to deliver the drug locally, potentially reducing side effects. The study focused on safety and how much drug enters the blood and vaginal fluids, not yet on how well it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
diclofenac vaginal gel
What this could lead to
If it works, this could offer a new, localized option for managing period pain with potentially fewer side effects than oral painkillers.
What could go wrong
This is a very early phase 1 trial with only 42 participants, focused on safety and drug levels, not on proving the gel actually relieves pain. The results may not lead to an effective treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSMENORRHEA PRIMARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PARC Clinical Research
Adelaide, Western Australia, Australia